Isabel Becker-Lastres

Castellana, MD 28046, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases.

Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases.

Journal: Journal of medicinal chemistry

Published: March 16, 2026

Analysis of the involvement of RNA-binding proteins in TAU-dependent neurodegeneration.

Analysis of the involvement of RNA-binding proteins in TAU-dependent neurodegeneration.

Journal: Neurobiology of disease

Published: March 06, 2026

Targeting pyroptosis in tauopathies: A redox-driven axis of neuroinflammation and neurodegeneration.

Targeting pyroptosis in tauopathies: A redox-driven axis of neuroinflammation and neurodegeneration.

Journal: Free radical biology & medicine

Published: February 10, 2026

Bioinformatic Analyses of the Ataxin-2 Family Since Algae Emphasize Its Small Isoforms, Large Chimerisms, and the Importance of Human Exon 1B as Target of Therapies to Prevent Neurodegeneration.

Bioinformatic Analyses of the Ataxin-2 Family Since Algae Emphasize Its Small Isoforms, Large Chimerisms, and the Importance of Human Exon 1B as Target of Therapies to Prevent Neurodegeneration.

Journal: International journal of molecular sciences

Published: January 09, 2026

NRF2 at the crossroads of Parkinson's disease and aging: Mechanistic insights and translational perspectives.

NRF2 at the crossroads of Parkinson's disease and aging: Mechanistic insights and translational perspectives.

Journal: Free radical biology & medicine

Published: December 17, 2025

NRF2 AT THE CROSSROADS OF PARKINSON'S DISEASE AND AGING: MECHANISTIC INSIGHTS AND TRANSLATIONAL PERSPECTIVES.

NRF2 AT THE CROSSROADS OF PARKINSON'S DISEASE AND AGING: MECHANISTIC INSIGHTS AND TRANSLATIONAL PERSPECTIVES.

Journal: Free radical biology & medicine

Published: December 17, 2025

GASDERMIN D-mediated pyroptosis as a therapeutic target in TAU-dependent frontotemporal dementia mouse model.

GASDERMIN D-mediated pyroptosis as a therapeutic target in TAU-dependent frontotemporal dementia mouse model.

Journal: Journal of biomedical science

Published: July 11, 2025

Corrigendum to "Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases" [Redox Biol. 79 (2025) 103464].

Corrigendum to "Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases" [Redox Biol. 79 (2025) 103464].

Journal: Redox biology

Published: January 20, 2025

RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection.

RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection.

Journal: Frontiers in neuroscience

Published: November 19, 2024

Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases.

Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases.

Journal: Redox biology

Published: October 25, 2024

Targeting CB2 receptor with a novel antagonist reverses cognitive decline, neurodegeneration and pyroptosis in a TAU-dependent frontotemporal dementia mouse model.

Targeting CB2 receptor with a novel antagonist reverses cognitive decline, neurodegeneration and pyroptosis in a TAU-dependent frontotemporal dementia mouse model.

Journal: Brain, behavior, and immunity

Published: September 23, 2024

Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia.

Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia.

Journal: Antioxidants (Basel, Switzerland)

Published: July 30, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026